Bibliography
- van der Bruggen P , TraversariC, ChomezPet al.: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.Science254 , 1643–1647 (1991).
- Rosenberg SA : A new era for cancer immunotherapy based on the genes that encode cancer antigens.Immunity10 , 281–287 (1999).
- Lapidot T , SirardC, VormoorJet al.: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.Nature367 , 645–648 (1994).
- Kanki K , TorigoeT, HiraiIet al.: Molecular cloning of rat NK target structure – the possibility of CD44 involvement in NK cell-mediated lysis.Microbiol. Immunol.44 , 1051–1061 (2000).
- Al-Hajj M , WichaMS, Benito-HernandezAet al.: Prospective identification of tumorigenic breast cancer cells.Proc. Natl Acad. Sci. USA100 , 3983–3988 (2003).
- Liu R , WangX, ChenGYet al.: The prognostic role of a gene signature from tumorigenic breast-cancer cells.N. Engl. J. Med.356 , 217–226 (2007).
- Dalerba P , DyllaSJ, ParkIKet al.: Phenotypic characterization of human colorectal cancer stem cells.Proc. Natl Acad. Sci. USA104 , 10158–10163 (2007).
- Li C , HeidtDG, DalerbaPet al.: Identification of pancreatic cancer stem cells.Cancer Res.67 , 1030–1037 (2007).
- Hurt EM , KawasakiBT, KlarmannGJet al.: CD44+ CD24- prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.Br. J. Cancer98 , 756–765 (2008).
- Prince ME , SivanandanR, KaczorowskiAet al.: Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma.Proc. Natl Acad. Sci. USA104 , 973–978 (2007).
- Takaishi S , OkumuraT, TuSet al.: Identification of gastric cancer stem cells using the cell surface marker CD44.Stem Cells27 , 1006–1020 (2009).
- Chan KS , EspinosaI, ChaoMet al.: Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells.Proc. Natl Acad. Sci. USA106 , 14016–14021 (2009).
- Yang ZF , HoDW, NgMNet al.: Significance of CD90+ cancer stem cells in human liver cancer.Cancer Cell13 , 153–166 (2008).
- Singh SK , ClarkeID, TerasakiMet al.: Identification of a cancer stem cell in human brain tumors.Cancer Res.63 , 5821–5828 (2003).
- Singh SK , HawkinsC, ClarkeIDet al.: Identification of human brain tumour initiating cells.Nature432 , 396–401 (2004).
- O‘Brien CA , PollettA, GallingerSet al.: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.Nature445 , 106–110 (2007).
- Ricci-Vitiani L , LombardiDG, PilozziEet al.: Identification and expansion of human colon-cancer-initiating cells.Nature445 , 111–115 (2007).
- Hermann PC , HuberSL, HerrlerTet al.: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.Cell Stem Cell1 , 313–323 (2007).
- Tirino V , DesiderioV, d‘AquinoRet al.: Detection and characterization of CD133+ cancer stem cells in human solid tumours.PLoS ONE3 , E3469 (2008).
- Shmelkov SV , ButlerJM, HooperATet al.: CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.J. Clin. Invest.118 , 2111–2120 (2008).
- Schatton T , MurphyGF, FrankNYet al.: Identification of cells initiating human melanomas.Nature451 , 345–349 (2008).
- Goodell MA , BroseK, ParadisGet al.: Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.J. Exp. Med.183 , 1797–1806 (1996).
- Kondo T , SetoguchiT, TagaT: Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line.Proc. Natl Acad. Sci. USA101 , 781–786 (2004).
- Haraguchi N , UtsunomiyaT, InoueHet al.: Characterization of a side population of cancer cells from human gastrointestinal system.Stem Cells24 , 506–513 (2006).
- Chiba T , KitaK, ZhengYWet al.: Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties.Hepatology44 , 240–251 (2006).
- Mitsutake N , IwaoA, NagaiKet al.: Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively.Endocrinology148 , 1797–1803 (2007).
- Wang J , GuoLP, ChenLZet al.: Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line.Cancer Res.67 , 3716–3724 (2007).
- Ho MM , NgAV, LamSet al.: Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.Cancer Res.67 , 4827–4833 (2007).
- Murase M , KanoM, TsukaharaTet al.: Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas.Br. J. Cancer101(8) , 1425–1432 (2009).
- Burkert J , OttoWR, WrightNA: Side populations of gastrointestinal cancers are not enriched in stem cells.J. Pathol.214 , 564–573 (2008).
- Ginestier C , HurMH, Charafe-JauffretEet al.: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.Cell Stem Cell1 , 555–567 (2007).
- Huang EH , HynesMJ, ZhangTet al.: Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.Cancer Res.69 , 3382–3389 (2009).
- Burger PE , GuptaR, XiongXet al.: High ALDH activity: a novel functional marker of murine prostate stem/progenitor cells.Stem Cells27(9) , 2220–2228 (2009).
- Ishikawa F , YasukawaM, LyonsBet al.: Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {γ} chain(null) mice.Blood106 , 1565–1573 (2005).
- Ishikawa F , YoshidaS, SaitoYet al.: Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.Nat. Biotechnol.25 , 1315–1321 (2007).
- Quintana E , ShackletonM, SabelMSet al.: Efficient tumour formation by single human melanoma cells.Nature456 , 593–598 (2008).
- Dean M , FojoT, BatesS: Tumour stem cells and drug resistance.Nat. Rev. Cancer5 , 275–284 (2005).
- Costello RT , MalletF, GauglerBet al.: Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.Cancer Res.60 , 4403–4411 (2000).
- Diehn M , ChoRW, LoboNAet al.: Association of reactive oxygen species levels and radioresistance in cancer stem cells.Nature458 , 780–783 (2009).
- Castriconi R , DagaA, DonderoAet al.: NK cells recognize and kill human glioblastoma cells with stem cell-like properties.J. Immunol.182 , 3530–3539 (2009).
- Todaro M , D‘AsaroM, CaccamoNet al.: Efficient killing of human colon cancer stem cells by γδ T lymphocytes.J. Immunol.182 , 7287–7296 (2009).
- Ishiyama S , MatsuedaS, JonesLAet al.: Novel natural immunogenic peptides from Numb1 and Notch1 proteins for CD8+ cells in ovarian ascites.Int. J. Oncol.30 , 889–898 (2007).
- Mine T , MatsuedaS, LiYet al.: Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cells.Cancer Immunol. Immunother.58 , 1185–1194 (2009).
- Brown CE , StarrR, MartinezCet al.: Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.Cancer Res.69 , 8886–8893 (2009).
- Ahmed N , SalsmanVS, KewYet al.: HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors.Clin. Cancer Res.16 , 474–485 (2010).
- Inoda S , HirohashiY, TorigoeTet al.: Cep55/c10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinoma.J. Immunother.32 , 474–485 (2009).
- Visus C , ItoD, AmoscatoAet al.: Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck.Cancer Res.67 , 10538–10545 (2007).
- Norde WJ , OveresIM, MaasFet al.: Myeloid leukemic progenitor cells can be specifically targeted by minor histocompatibility antigen LRH-1-reactive cytotoxic T cells.Blood113 , 2312–2323 (2009).
- Schmitz M , TemmeA, SennerVet al.: Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy.Br. J. Cancer96 , 1293–1301 (2007).
- Steele JC , TorrEE, NoakesKLet al.: The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens.Br. J. Cancer95 , 1202–1211 (2006).
- Hirohashi Y , TorigoeT, MaedaAet al.: An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin.Clin. Cancer Res.8 , 1731–1739 (2002).
- Idenoue S , HirohashiY, TorigoeTet al.: A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins.Clin. Cancer Res.11 , 1474–1482 (2005).
- Sato N , HirohashiY, TsukaharaTet al.: Molecular pathological approaches to human tumor immunology.Pathol. Int.59 , 205–217 (2009).
- Hirohashi Y , TorigoeT, InodaSet al.: The functioning antigens: beyond just as the immunological targets.Cancer Sci.100 , 798–806 (2009).
- Hariu H , HirohashiY, TorigoeTet al.: Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer.Clin. Cancer Res.11 , 1000–1009 (2005).
- Ochi T , FujiwaraH, SuemoriKet al.: Aurora-A kinase: a novel target of cellular immunotherapy for leukemia.Blood113 , 66–74 (2009).
- Tajima K , DemachiA, ItoYet al.: Identification of an epitope from the epithelial cell adhesion molecule eliciting HLA-A*2402-restricted cytotoxic T-lymphocyte responses.Tissue Antigens64 , 650–659 (2004).
- Dallas NA , XiaL, FanFet al.: Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition.Cancer Res.69 , 1951–1957 (2009).
- Hoey T , YenWC, AxelrodFet al.: DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency.Cell Stem Cell5 , 168–177 (2009).
- Majeti R , ChaoMP, AlizadehAAet al.: CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.Cell138 , 286–299 (2009).
- Jaiswal S , JamiesonCH, PangWWet al.: CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis.Cell138 , 271–285 (2009).
- Taniguchi M , TashiroT, DashtsoodolNet al.: The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy.Int. Immunol.22 , 1–6 (2010).
- Bellone M , CecconM, GrioniMet al.: iNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T cells.PLoS ONE5 , E8646 (2010).
- Xu Q , LiuG, YuanXet al.: Antigen-specific T cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens.Stem Cells27(8) , 1734–1740 (2009).
- Koebel CM , VermiW, SwannJBet al.: Adaptive immunity maintains occult cancer in an equilibrium state.Nature450 , 903–907 (2007).
- Mani SA , GuoW, LiaoMJet al.: The epithelial-mesenchymal transition generates cells with properties of stem cells.Cell133 , 704–715 (2008).
- Kudo-Saito C , ShirakoH, TakeuchiTet al.: Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells.Cancer Cell15 , 195–206 (2009).